ACLU to Myriad Genetics: Patients, not companies, own personal genetic data

Screen Shot at AM

Ken Deutsch was diagnosed with metastatic bladder cancer two years ago. As part of his treatment plan, he was genetically tested for genetic mutations by Myriad Genetics, a company that specializes in identifying cancer genes.

But when Deutsch wanted to share the full results of that testing with researchers at the National Institutes of Health, Myriad refused to release it. While the company gave him his results for cancer, Myriad also looks at other mutations in these cancer genes. These are benign mutations that are not known to increase cancer risk and, as a result, aren’t usually reported back to patients. But Deutsch wanted these data included in the information he submitted to the ClinVar network, a database of patients’ genetic information run by the NIH. Myriad said no.

Deutsch was not alone. He and three other Myriad customers are named as complainants in a formal action filed by the ACLU on May 17, 2016 with the U.S. Department of Health and Human Services. The complainants want Myriad to release this information to anyone who wants it saying they as patients and customers have the right to their own medical information under the Health Insurance Portability and Accountability Act (HIPAA). From STAT:

The Health Insurance Portability and Accountability Act (HIPAA), mostly known for its protections on patients’ privacy, also includes provisions guaranteeing patients access to their health information. A complaint filed on Thursday by the American Civil Liberties Union claims that Myriad has violated HIPAA by refusing to provide the full gene data that they generated from patients.

The day after the complaint was filed Myriad provided the information to the four patients. A spokesman for Myriad told Bloomberg that the patients should withdraw the complaint, accordingly. But the ACLU declined. From Bloomberg:

A patient’s right to their entire genetic record set is a focus of the ACLU, Sandra Park, a senior attorney with the ACLU, told Bloomberg BNA May 20. Park said the complaint is the ACLU’s first foray into ensuring patients’ full access to their medical records. She said the ACLU is looking for Myriad to willingly acknowledge a patient’s right to full access, either through a voluntary posting on its website or through a resolution agreement.

In 2013, Myriad lost a high profile Supreme Court case over the patent rights to the BRCA1 & 2 genes, which are linked to higher incidences of breast, ovarian and prostate cancer. The case set the precedence that naturally occurring DNA cannot be patented.

Related article:  Why regulators conclude glyphosate safe while IARC, alone, claims it could cause cancer?

ACLUgene
Beyond patient access, there is a second issue with the fact that Myriad is collecting and keeping results on benign mutations. Sometimes these mutations do turn out to be disease-linked. When they are, there is not standardized notification to patients. Last year a two-year-old boy died because a mutation that his genetic testing lab classified as benign turned out not to be. That case spotlighted the lack of follow up communication between testing companies and patients about mutations. It also highlighted the need for non-profit databases like ClinVar to speed up the process of implicating or exonerating unknown mutations in causing disease.

Patients who are willing to accept the potential risks of sharing their genetic information for research purposes should not be kept from that because of the wishes of the company that did their testing. Nor should these companies sequester a patient’s data while they wait to discover its significance for themselves.

Meredith Knight is a contributor to the human genetics section for Genetic Literacy Project and a freelance science and health writer in Austin, Texas. Follow her @meremereknight.

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend